Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation

Clin Radiol. 2014 Oct;69(10):1034-8. doi: 10.1016/j.crad.2014.05.106. Epub 2014 Jul 10.

Abstract

Aim: To identify independent predictors of contrast medium-induced acute kidney injury (CI-AKI) after enhanced multidetector-row computed tomography (MDCT) prior to transcatheter aortic valve implantation (TAVI) in high-risk patients.

Materials and methods: The present single-centre study analysed retrospectively 361 patients who were assessed using MDCT prior to TAVI. CI-AKI was defined as an increase in serum creatinine (SCr) of ≥ 25% or ≥ 0.5 mg/dl in at least one sample over baseline (24 h before MDCT) and at 24, 48, and 72 h after MDCT.

Results: A total of 38 patients (10.5%) experienced CI-AKI. As compared to patients without CI-AKI, they presented more frequently with estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2), (81.6% versus 64.4%, p = 0.045) and tended to receive higher volumes of iodinated contrast media (ICM; 55.3% versus 39%, p = 0.057). There was a significant interaction between baseline eGFR and the amount of intravenous ICM administered (pfor interaction = <0.001) identifying the amount of ICM >90 ml as independent predictive factor of CI-AKI only in patients with baseline eGFR <60 ml/min/1.73m(2) (OR 2.615; 95% CI: 1.21-5.64).

Conclusion: One in ten elderly patients with aortic stenosis undergoing MDCT to plan a TAVI procedure experienced CI-AKI after intravenous ICM injection. Intravenous administration of <90 ml of ICM reduces this risk in patients with or without pre-existing impaired renal function. However, in the majority of patients renal function recovers before the TAVI procedure.

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Aged, 80 and over
  • Aortic Valve / diagnostic imaging*
  • Aortic Valve / surgery
  • Cardiac Catheterization / methods*
  • Contrast Media / adverse effects*
  • Female
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation / methods
  • Humans
  • Iopamidol / adverse effects
  • Iopamidol / analogs & derivatives*
  • Male
  • Multidetector Computed Tomography / methods*
  • Retrospective Studies
  • Risk Factors

Substances

  • Contrast Media
  • iomeprol
  • Iopamidol